Target intelligence / Profile preview

Human serum albumin–copper complex

Molecular classification
Other (metal–protein complex), Protein (carrier protein)
01

Overview

Human serum albumin (HSA) is the most abundant plasma protein and serves as a key transporter of metal ions, notably copper (Cu(II)), in blood. Roughly 15% of circulating plasma copper is bound to albumin, with the remainder mainly associated with ceruloplasmin (70%) and alpha-2-macroglobulin (10%). Albumin binds Cu(II) with high affinity at its amino-terminal site, forming a labile pool readily exchangeable with cellular transporters such as copper transporter 1 (Ctr1). This copper pool is essential for distribution and homeostasis, but HSA–copper is not itself a conventional pharmacological target[2][3][6][1]. Albumin–copper interactions play important roles in detoxifying redox-active copper and delivering copper to tissues, and are relevant for understanding oral copper uptake, inherited copper metabolism disorders, and the pharmacodynamics of certain copper-chelating anticancer drugs[1][2][4][6].

Other names
Albumin–copper complexHSA–copper complexHuman serum albumin–Cu(II) complex
02

Mechanism of action

Chelation and removal of Cu(II) from albumin binding site

03

Biological functions

Copper transport in plasmaMetal ion buffering and detoxificationDelivery of copper to cells
04

Disease associations

Copper metabolism disorders (e.g., Wilson’s disease, Menkes disease)Neurodegenerative diseasesOther (general relevance to copper homeostasis, but not itself a disease gene/protein)
05

Safety considerations

Chelation of albumin-bound copper could disrupt copper homeostasis, which carries a risk in patients with underlying metabolic disorders
06

Interacting drugs

Metal chelators (e.g., penicillamine, trientine, thiosemicarbazones for research/anticancer use)
07

Biomarkers

Blood serum copper bound to albumin can be reflective of copper status in metabolic or genetic copper disorders

Beyond the preview

Go deeper on Human serum albumin–copper complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human serum albumin–copper complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call